[ Price : $8.95]
FDA tentatively approves an Impax Labs ANDA for a generic version of Wyeths Effexor XR.[ Price : $8.95]
Pfizer decides to abandon its inhaled insulin product Exubera after disappointing sales and physician resistance.[ Price : $8.95]
FDA approves J&Js Doribax for treating complicated urinary tract and intra-abdominal infections.[ Price : $8.95]
FDA issues a guidance in conjunction with a notice classifying remote medication management systems as Class 2.[ Price : $8.95]
CDER publishes a guidance on using mechanical calibration as an alternate to calibrator tablets in dissolution testing apparatus.[ Price : $8.95]
Consulting editor John Scharmann reviews CVMs recent approval of florfenicol in the light of growing concern about antibiotic-resi...[ Price : $8.95]
A GAO report finds continuing internal CDRH disagreement with FDAs 2001 approval of a device made by TMJ Implants Inc., now fighti...[ Price : $8.95]
FDA clears a bioMrieux 510(k) for the Vidas Brahms PCT test for assessing a patients risk for developing severe sepsis.